Table 3 Deterministic & probabilistic results for ranolazine plus SoC vs SoC alone
Deterministic results | Probabilistic results | |||||
|---|---|---|---|---|---|---|
Costs | Ranolazine | SoC | Incremental | Ranolazine | SoC | Incremental |
Mean (95 % CI) | ||||||
Total Costs (€) | 1170 | 984 | 186 | 1170 (1123; 1213) | 985 (933; 1036) | 184 (154; 216) |
Health outcomes | ||||||
QALYs | 0.3155 | 0.2752 | 0.0403 | 0.3157 (0.3093; 0.3221) | 0.2754 (0.2672; 0.2836) | 0.0402 (0.0345; 0.0456) |
Incremental analysis | ||||||
ICER per QALY (€) | 4620 | 4904 (3526; 5962) | ||||